Ligand validation:3ABO

B12: COBALAMIN

B12 is a Ligand Of Interest in 3ABO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ABO_B12_B_601	62%	38%	0.147	0.94	1.4	1.06	13	8	2	0	100%	1
3ABO_B12_D_601	55%	39%	0.152	0.919	1.28	1.1	11	11	2	0	100%	1
5YSN_B12_B_601	95%	27%	0.081	0.985	1.66	1.28	9	20	0	0	100%	1
7XRM_B12_B_301	80%	36%	0.121	0.97	1.33	1.18	11	14	1	0	100%	1
3ABQ_B12_B_601	75%	34%	0.122	0.954	1.34	1.27	10	18	1	0	100%	1
7XRN_B12_D_601	71%	36%	0.132	0.953	1.32	1.19	10	16	1	0	100%	1
3ABR_B12_D_601	70%	30%	0.124	0.941	1.28	1.52	10	24	2	0	100%	1
3KQ4_B12_E_2007	100%	12%	0.04	0.996	1.51	2.55	10	38	4	1	100%	1
8IXU_B12_A_501	100%	63%	0.045	0.99	0.63	0.79	1	3	0	0	100%	1
4LEM_B12_A_601	99%	19%	0.051	0.98	1.29	2.13	8	34	0	0	100%	1
8IXT_B12_A_501	99%	60%	0.064	0.991	0.7	0.81	2	2	0	0	100%	1
4NS3_B12_A_601	98%	12%	0.056	0.974	1.45	2.57	9	30	1	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.